merged_engineered-virus-steals-proteins-from-hiv.txt
<question_number>1</question_number>
<answer>Cost and administration frequency</answer>
<question_number>2</question_number>
<answer>Reduced transmission of H.I.V.</answer>
<question_number>3</question_number>
<answer>Permanent integration into the patient's DNA</answer>
<question_number>4</question_number>
<answer>Targeting the virus's life cycle by competing for resources</answer>
<question_number>5</question_number>
<answer>Potential for unexpected side effects and unremovability</answer>
<question_number>6</question_number>
<answer>Ability to replicate and produce more TIPs than H.I.V. viruses</answer>
<question_number>7</question_number>
<answer>Unexpected side effects and potential for spread to others</answer>
<question_number>8</question_number>
<answer>In principle, it's a universal approach to developing antivirals</answer>
<question_number>9</question_number>
<answer>Consent cannot be obtained from those who might be infected by the patient</answer>
<question_number>10</question_number>
<answer>TIPs compete with H.I.V. for resources, rather than directly attacking the virus</answer>